In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other best multibagger stocks to buy according to billionaires. US Trade tariffs have ...

In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock ...

ADMA Biologics ADMA reported lower-than-expected results for the first quarter. Adjusted earnings per share of 14 cents missed the Zacks Consensus Estimate of 16 cents. Revenues of $114.8 million ...

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript ADMA Biologics slips as 10-K delay overshadows earnings beat ADMA Biologics GAAP EPS of $0.46 beats by $0.31, revenue of $117.55M beats ...

RAMSEY, N.J. and BOCA RATON, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end ...

Adma Biologics shares have risen 38% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $23.61, more than tripling in the last 12 months.

ADMA delivered outstanding financial and operational results in the first quarter of 2025, with total reported revenues and Adjusted EBITDA growing by 40% and 81% year-over-year, respectively ...

Shares of ADMA Biologics, Inc. ADMA have gained 48.6% (versus the S&P 500’s 3% decrease) since it was upgraded to a Zacks Rank #2 (Buy) on March 4. Another stock, Intrepid Potash, Inc. IPI ...